Profil
Actuellement, Zheru Zhang est président et directeur d'I-Mab et président d'I-Mab Biopharma (Shanghai) Co., Ltd. (une filiale d'I-Mab). Dans sa carrière antérieure, le Dr Zhang a été directeur général de Shanghai Jmt Bio Co. Ltd, vice-président de la recherche et du développement pour Celltrion, Inc. et président de I-Mab Bio-tech (Tianjin) Co., Ltd. Le Dr Zhang a obtenu un diplôme d'études supérieures de l'université de Soochow et un doctorat de l'université d'Alberta.
Anciens postes connus de Zheru Zhang
| Sociétés | Poste | Fin |
|---|---|---|
| I-MAB | President | 31/08/2022 |
I-Mab Bio-tech (Tianjin) Co. Ltd.
 I-Mab Bio-tech (Tianjin) Co. Ltd. BiotechnologyHealth Technology I-Mab Bio-tech (Tianjin) Co., Ltd. engages in the research and development of medicine and biological products. Its business activities include investment information consultation, and health information services. The company was founded on April 19, 2012 and is headquartered in Tianjin, China. | President | 01/04/2017 |
| Shanghai JMT-BIO Technology Co., Ltd. | Chief Executive Officer | 01/10/2015 |
| CELLTRION, INC. | Chief Tech/Sci/R&D Officer | 01/10/2012 |
I-MAB Biopharma Co., Ltd.
 I-MAB Biopharma Co., Ltd. BiotechnologyHealth Technology I-Mab Biopharma (Shanghai) Co., Ltd. engages in the development of biologics. It focuses on monoclonal antibodies or bi-specific antibodies in the areas of immuno-oncology and autoimmune diseases. The company was founded by Jingwu Zang in March 2017 and is headquartered in Shanghai, China. | President | - |
Formation de Zheru Zhang
| University of Alberta | Doctorate Degree |
| Soochow University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| CELLTRION, INC. | Health Technology |
| I-MAB | Health Technology |
| Entreprise privées | 3 |
|---|---|
I-Mab Bio-tech (Tianjin) Co. Ltd.
I-Mab Bio-tech (Tianjin) Co. Ltd. BiotechnologyHealth Technology I-Mab Bio-tech (Tianjin) Co., Ltd. engages in the research and development of medicine and biological products. Its business activities include investment information consultation, and health information services. The company was founded on April 19, 2012 and is headquartered in Tianjin, China. | Health Technology |
I-MAB Biopharma Co., Ltd.
I-MAB Biopharma Co., Ltd. BiotechnologyHealth Technology I-Mab Biopharma (Shanghai) Co., Ltd. engages in the development of biologics. It focuses on monoclonal antibodies or bi-specific antibodies in the areas of immuno-oncology and autoimmune diseases. The company was founded by Jingwu Zang in March 2017 and is headquartered in Shanghai, China. | Health Technology |
| Shanghai JMT-BIO Technology Co., Ltd. |
